Your browser doesn't support javascript.
loading
Non-medical switch from the originator to biosimilar and between biosimilars of adalimumab in inflammatory bowel disease - a prospective, multicentre study.
Lontai, Livia; Gonczi, Lorant; Balogh, Fruzsina; Komlodi, Nora; Resal, Tamas; Farkas, Klaudia; Molnar, Tamas; Miheller, Pal; Golovics, Petra A; Schafer, Eszter; Szamosi, Tamas; Ilias, Akos; Lakatos, Peter L.
Afiliação
  • Lontai L; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.
  • Gonczi L; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.
  • Balogh F; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.
  • Komlodi N; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.
  • Resal T; Department of Medicine, University of Szeged, Szeged, Hungary.
  • Farkas K; Department of Medicine, University of Szeged, Szeged, Hungary.
  • Molnar T; Department of Medicine, University of Szeged, Szeged, Hungary.
  • Miheller P; Department of Surgery, Transplantation and Gastroenterology, Semmelweis University, Budapest, Hungary.
  • Golovics PA; Department of Gastroenterology, Hungarian Defense Forces Medical Centre, Budapest, Hungary.
  • Schafer E; Department of Gastroenterology, Hungarian Defense Forces Medical Centre, Budapest, Hungary.
  • Szamosi T; Department of Gastroenterology, Hungarian Defense Forces Medical Centre, Budapest, Hungary.
  • Ilias A; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.
  • Lakatos PL; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary; Division of Gastroenterology, McGill University Health Center, Montreal, Quebec, Canada. Electronic address: Peter.Lakatos@muhc.mcgill.ca.
Dig Liver Dis ; 54(12): 1639-1645, 2022 12.
Article em En | MEDLINE | ID: mdl-35931624

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Medicamentos Biossimilares Tipo de estudo: Clinical_trials / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Medicamentos Biossimilares Tipo de estudo: Clinical_trials / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article